Aristotle University Of Thessaloniki (AUTH)
Συγκριτική μελέτη δύο σχημάτων ινσουλινοθεραπείας σε ασθενείς με σακχαρώδη διαβήτη τύπου 2 με την χρήση αισθητήρων γλυκόζης
Abstract
dc:descriptionAim: To compare in terms of glycemic variability two premixed insulins, Premixed HumanInsulin 30/70 (PHI) and Biphasic Aspart 30 (BiAsp30), using Continuous Glucose Monitoring (CGM)and to estimate the correlation of Glycated Albumin (GA) and Fructosamine (FA) with CGM data.Patients-Data: A total of 36 well-controlled patients with type 2 Diabetes Mellitus (T2DM) underwent7-day CGM with PHI and subsequently with BiAsp30. GA and FA were measured at the first and lastday of each week of CGM. Results: BiAsp30 was associated with lower Average Blood Glucose(ABG) during the 23:00–03:00 period (PHI: 135.08 28.94 mg/dL, BiAsp30: 117.75 21.24 mg/dL,p < 0.001) and the 00:00–06:00 period (PHI: 120.42 23.13 mg/dL, BiAsp30: 111.17 14.74 mg/dL,p = 0.008), as well as with more time below range (<70 mg/dL) (TBR) during the 23:00–03:00 periodin the week (PHI: 3.65 5.93%, BiAsp30: 11.12 16.07%, p = 0.005). PHI was associated withlower ABG before breakfast (PHI: 111.75 23.9 mg/dL, BiAsp30: 128.25 35.9 mg/dL, p = 0.013).There were no differences between the two groups in ABG, Time In Range and Time Below Rangeduring the entire 24-h period for 7 days, p = 0.502, p = 0.534, and p = 0.258 respectively, and inTBR for the 00:00–06:00 period p = 0.253. Total daily insulin requirements were higher for BiAsp30(PHI: 47.92 12.18 IU, BiAsp30: 49.58 14.12 IU, p = 0.001). GA and FA correlated significantlywith ABG (GA: r = 0.512, p = 0.011, FA: r = 0.555, p = 0.005). Conclusions: In well-controlled patientswith T2DM, BiAsp30 is an equally effective alternative to PHI.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Margaritidis, Charalampos
- Μαργαριτίδης, Χαράλαμπος
Subjects
dc:subject × 16- Αισθητήρες γλυκόζης
- Συνεχής καταγραφή γλυκόζης
- Μίγματα ινσουλίνης
- Σακχαρώδης Διαβήτης (ΣΔ)
- Glucose sensors
- Continuous Glucose Monitoring
- Premixed insulins
- Diabetes mellitus
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ενδοκρινολογία, Διαβήτης και Μεταβολισμός
- Γενική και Εσωτερική ιατρική
- Clinical Medicine
- Medical and Health Sciences
- Endocrinology, Diabetes and Metabolism
- General and Internal Medicine
Rights
dc:rights- Statement dc:rights
-
- BY_NC_ND_4_0
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/49453